Nilotinib - Wikipedia, the free encyclopedia
It was approved as Tasigna in the USA and the EU for drug-resistant chronic ... "FDA Approves Tasigna for Treatment of Philadelphia Chromosome Positive ...
http://en.wikipedia.org/wiki/Nilotinib...
|
Novartis drug Tasigna® meets primary endpoint in pivotal trial ...
20 Oct 2009 ... Tasigna produced faster and deeper responses compared to Glivec as first-line treatment in Philadelphia chromosome-positive chronic myeloid ...
http://www.novartis.com/newsroom/media-releases/en/2009/1348...
|
2 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not ...
Tasigna prolongs the QT interval (5.2). Sudden deaths have been reported in patients receiving nilotinib (5.3). Tasigna should ...
http://www.pharma.us.novartis.com/product/pi/pdf/tasigna.pdf...
|
FDA Safety Changes: Metronidazole Injection, DexFerrum, INFeD, Tasigna
23 Sep 2009 ... The FDA has approved safety labeling revisions for metronidazole injection, iron dextran injection (DexFerrum and INFeD), and nilotinib HCl ...
http://www.medscape.com/viewarticle/709381...
|
TASIGNA (ta-sig-na) (nilotinib) Capsules Read this Medication ...
Read this Medication Guide before you start taking Tasigna ... What is the most important information I should know about Tasigna? ...
http://www.pharma.us.novartis.com/product/pi/pdf/tasigna_pmg...
|
Tasigna® gains European approval for patients with a life ...
28 Nov 2007 ... Basel, November 28, 2007 - Tasignaâ (nilotinib) has received European Union approval as a new anti-cancer therapy for patients with a ...
http://www.novartis.com/newsroom/media-releases/en/2007/1171...
|
Tasigna (nilotinib) capsules
15 Sep 2009 ... Tasigna (nilotinib) capsules Drug Safety Labeling Changes August 2009 MedWatch.
http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm1822...
|
Tasigna® demonstrates rapid response as initial therapy in life ...
8 Dec 2008 ... Tasigna now shows potential to become the treatment of choice for certain newly diagnosed patients with chronic myeloid leukemia ...
http://www.novartis.com/newsroom/media-releases/en/2008/1275...
|
FDA Approves Tasigna for Treatment of Philadelphia Chromosome ...
30 Oct 2007 ... The US Food and Drug Administration (FDA) has approved Tasigna (nilotinib) capsules for treatment of Philadelphia chromosome positive ...
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/20...
|
Tasigna® shows rapid and deep responses in newly diagnosed ...
5 Jun 2009 ... Basel, June 5, 2009 - New data show that at 12 months newly diagnosed patients taking Tasigna® (nilotinib) to treat a life-threatening form ...
http://www.novartis.com/newsroom/media-releases/en/2009/1320...
|
